Francisco A. Bustamante

Francisco A. Bustamante, MBA, currently serves as President at ARx, LLC, where the focus is on innovative drug delivery systems, specifically drug-loaded dissolvable films and transdermal patches. Prior to this role, Francisco held the position of General Manager and Site Lead at Catalent Pharma Solutions, overseeing particle size engineering technologies. Previous experience includes serving as President at Lifeline Cell Technology, General Manager and VP of Operations at MESO SCALE DIAGNOSTICS, and Senior Manager roles at both QIAGEN and Lonza, specializing in production planning and supply chain management. Francisco began a career in manufacturing and production planning as Manager at Clonetics. Educational qualifications include a Bachelor of Arts in Biology from the University of San Diego and an MBA from Frostburg State University.